PLSE beat EPS expectations by 8.29%
Nov 05, 2025, 11:37 PM
0.00%
What does PLSE do
Pulse Biosciences, based in Hayward, California, develops proprietary oncolytic electroceutical therapies using Nano Pulse Stimulation (NPS) technology for various medical applications. The company went public on May 18, 2016, and employs 56 staff.
Pulse Biosciences (PLSE) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Pulse Biosciences's actual EPS was -$0.29, beating the estimate of -$0.32 per share, resulting in a 8.29% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.